2325 related articles for article (PubMed ID: 21620466)
1. Pancreatic cancer.
Vincent A; Herman J; Schulick R; Hruban RH; Goggins M
Lancet; 2011 Aug; 378(9791):607-20. PubMed ID: 21620466
[TBL] [Abstract][Full Text] [Related]
2. Advances in pancreatic cancer research: moving towards early detection.
He XY; Yuan YZ
World J Gastroenterol; 2014 Aug; 20(32):11241-8. PubMed ID: 25170208
[TBL] [Abstract][Full Text] [Related]
3. Familial Pancreatic Cancer.
Benzel J; Fendrich V
Oncol Res Treat; 2018; 41(10):611-618. PubMed ID: 30269130
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer: An update on diagnosis and management.
Loveday BPT; Lipton L; Thomson BN
Aust J Gen Pract; 2019 Dec; 48(12):826-831. PubMed ID: 31774983
[TBL] [Abstract][Full Text] [Related]
6. [Pancreatic ductal adenocarcinoma].
Gallmeier E; Gress TM
Internist (Berl); 2018 Aug; 59(8):805-822. PubMed ID: 29980819
[TBL] [Abstract][Full Text] [Related]
7. Imaging of pancreatic neoplasms.
Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
[TBL] [Abstract][Full Text] [Related]
8. Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions.
Bararia A; Dey S; Gulati S; Ghatak S; Ghosh S; Banerjee S; Sikdar N
Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):205-217. PubMed ID: 32312637
[TBL] [Abstract][Full Text] [Related]
9. Organoid models for translational pancreatic cancer research.
Tiriac H; Plenker D; Baker LA; Tuveson DA
Curr Opin Genet Dev; 2019 Feb; 54():7-11. PubMed ID: 30844513
[TBL] [Abstract][Full Text] [Related]
10. New Diagnostic and Therapeutic Aspects of Pancreatic Ductal Adenocarcinoma.
Mangge H; Niedrist T; Renner W; Lyer S; Alexiou C; Haybaeck J
Curr Med Chem; 2017; 24(28):3012-3024. PubMed ID: 28494747
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
Grossberg AJ; Chu LC; Deig CR; Fishman EK; Hwang WL; Maitra A; Marks DL; Mehta A; Nabavizadeh N; Simeone DM; Weekes CD; Thomas CR
CA Cancer J Clin; 2020 Sep; 70(5):375-403. PubMed ID: 32683683
[TBL] [Abstract][Full Text] [Related]
12. [Pathogenesis of the ductal pancreatic adenocarcinoma: implications for future therapies?].
Schneider G; Schmid RM
Internist (Berl); 2005 Feb; 46(2):157-65. PubMed ID: 15655682
[TBL] [Abstract][Full Text] [Related]
13. Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.
Hidalgo M; Álvarez R; Gallego J; Guillén-Ponce C; Laquente B; Macarulla T; Muñoz A; Salgado M; Vera R; Adeva J; Alés I; Arévalo S; Blázquez J; Calsina A; Carmona A; de Madaria E; Díaz R; Díez L; Fernández T; de Paredes BG; Gallardo ME; González I; Hernando O; Jiménez P; López A; López C; López-Ríos F; Martín E; Martínez J; Martínez A; Montans J; Pazo R; Plaza JC; Peiró I; Reina JJ; Sanjuanbenito A; Yaya R; Carrato A
Clin Transl Oncol; 2017 Jun; 19(6):667-681. PubMed ID: 27995549
[TBL] [Abstract][Full Text] [Related]
14. Major molecular markers in pancreatic ductal adenocarcinoma and their roles in screening, diagnosis, prognosis, and treatment.
Singh P; Srinivasan R; Wig JD
Pancreas; 2011 Jul; 40(5):644-52. PubMed ID: 21673535
[TBL] [Abstract][Full Text] [Related]
15. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
Christenson ES; Jaffee E; Azad NS
Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
Mardin WA; Mees ST
Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
[TBL] [Abstract][Full Text] [Related]
17. Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion.
Stoffel EM; McKernin SE; Brand R; Canto M; Goggins M; Moravek C; Nagarajan A; Petersen GM; Simeone DM; Yurgelun M; Khorana AA
J Clin Oncol; 2019 Jan; 37(2):153-164. PubMed ID: 30457921
[TBL] [Abstract][Full Text] [Related]
18. Multimodality therapy offers a chance for cure in patients with pancreatic adenocarcinoma deemed unresectable at first operative exploration.
Truty MJ; Thomas RM; Katz MH; Vauthey JN; Crane C; Varadhachary GR; Wolff RA; Abbruzzese JL; Lee JE; Fleming JB
J Am Coll Surg; 2012 Jul; 215(1):41-51; discussion 51-2. PubMed ID: 22608401
[TBL] [Abstract][Full Text] [Related]
19. Molecular mediators of peritoneal metastasis in pancreatic cancer.
Avula LR; Hagerty B; Alewine C
Cancer Metastasis Rev; 2020 Dec; 39(4):1223-1243. PubMed ID: 32780245
[TBL] [Abstract][Full Text] [Related]
20. Genomics of pancreatic ductal adenocarcinoma.
Pilarsky C; Grutzmann R
Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
